Beone Medicines (ONC)Global Head of R&D sold ~$88K

~$88K

Approx. value · 292 sh @ $302.92

1,059

Holds after · shares reported

Traded

Jul 29, 2025

Filed

Jul 31, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Jun 6, 2025Insider · 4 peopleInsiders: 16 sales (~$2.3M)
2. Jun 10, 2025Insider · 1 personInsiders: 5 sales (~$11.0M)
3. Jun 11, 2025InsiderOfficer sold ~$35K of ONC shares in the open market
4. Jun 16, 2025Insider · 4 peopleInsiders: 5 sales (~$1.8M)
5. Jun 17, 2025Insider · 3 peopleInsiders: 3 sales (~$651K)
6. Jun 23, 2025Insider · 3 peopleInsiders: 4 sales (~$1.5M)
7. Jun 24, 2025Insider · 1 personInsiders: 4 sales (~$533K)
8. Jul 9, 2025Insider · 1 personInsiders: 4 sales (~$7.0M)
9. Jul 18, 2025InsiderOfficer sold ~$210K of ONC shares in the open market
10. Jul 29, 2025 · this disclosureInsiderOfficer sold ~$88K of ONC shares in the open market

What came next

1. Jul 29, 2025Insider · 1 personInsiders: 2 sales (~$1.1M)
2. Jul 30, 2025Insider · 2 peopleInsiders: 2 sales (~$359K)
3. Aug 1, 2025InsiderCFO sold ~$346K of ONC shares in the open market
4. Aug 13, 2025Insider · 2 peopleInsiders: 11 sales (~$18.5M)
5. Aug 14, 2025Insider · 1 personInsiders: 8 sales (~$12.2M)
6. Sep 2, 2025InsiderOfficer sold ~$40K of ONC shares in the open market
7. Sep 5, 2025InsiderDirector sold ~$898K of ONC shares in the open market
8. Sep 9, 2025Insider · Their largest sale since 2021Officer sold ~$1.75M of ONC shares in the open market
9. Sep 10, 2025Insider · 1 personInsiders: 5 sales (~$3.3M)
10. Sep 16, 2025Insider · 1 personInsiders: 4 sales (~$7.7M)
11. Nov 6, 2025Company filing · Form 8-K · ResultsReported its results
12. Nov 13, 2025Company filing · Form 8-K · Material agreement, New debtSigned an important agreement, and took on new debt or obligations

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Beone Medicines

For Beone Medicines, OQRO holds 11 insider filings (SEC Form 4 or Form 144) and 6 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ONC page.

Other recent filings by Lai Wang, Global Head of R&D

• SEC Form 4 at Beone Medicines (ONC)Sep 11, 2025
• SEC Form 4 at Beone Medicines (ONC)Jul 31, 2025
• SEC Form 4 at Beone Medicines (ONC)Jul 31, 2025
• SEC Form 4 at Beone Medicines (ONC)Jul 31, 2025
• SEC Form 4 at Beone Medicines (ONC)Jul 22, 2025

The full history of Lai Wang, Global Head of R&D is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Beone Medicines

• SEC Form 4Oct 2, 2026
• SEC Form 4Sep 30, 2026
• SEC Form 4Sep 30, 2026
• SEC Form 4Sep 30, 2026
• SEC Form 4Sep 30, 2026
• SEC Form 4Sep 30, 2026

Everything OQRO holds on this company is on its ONC page.